Adding PD-1 Inhibitors to Rectal Cancer Therapy Linked to Higher Complete Response Rates
A retrospective study of 84 rectal cancer patients found that adding a PD-1 inhibitor to neoadjuvant chemoradiotherapy was associated with ...
A retrospective study of 84 rectal cancer patients found that adding a PD-1 inhibitor to neoadjuvant chemoradiotherapy was associated with ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.